Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections.

Bork, Jacqueline T; Heil, Emily L; Berry, Shanna; Lopes, Eurides; Davé, Rohini; Gilliam, Bruce L; Amoroso, Anthony

Bork, Jacqueline T; Heil, Emily L; Berry, Shanna; Lopes, Eurides; Davé, Rohini; Gilliam, Bruce L; Amoroso, Anthony.

Afiliación

Bork JT; Division of Infectious Disease, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. jabork@som.umaryland.edu.
Heil EL; Department of Medicine, VA Maryland Health Care System, Baltimore, MD, USA. jabork@som.umaryland.edu.
Berry S; University of Maryland School of Pharmacy, Baltimore, MD, USA.
Lopes E; Division of Infectious Disease, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Davé R; Division of Infectious Disease, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Gilliam BL; Department of Pharmacy, VA Maryland Health Care System, Baltimore, MD, USA.
Amoroso A; Division of Infectious Disease, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Infect Dis Ther ; 8(2): 171-184, 2019 Jun.

Article en En | MEDLINE | ID: mdl-31054088

Palabras clave

Dalbavancin; Outpatient parenteral antibiotic therapy; Substance use disorder

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Infect Dis Ther Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google